Waga, Ruth P.

HRN: 03-01-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/05/2025
08/12/2025
IVTT
2.25gm
Q6
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines